IndraLab

Statements

UCHL5 bound to NFRKB inhibits NFRKB. 2 / 2
| 2
reach
"In gastric cancer, DRAIC combined with UCHL5 to attenuate the binding of UCHL5 and NFRKB, thereby promoting the degradation of NFRKB via ubiquitination and inhibiting the proliferation and metastasis [MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"
36328194
reach
"DRAIC combined with UCHL5 and attenuated binding of UCHL5 and NFRKB, meanwhile promoting the degradation of NFRKB via ubiquitination, and then inhibited the proliferation and metastasis of GC cells, which can be rescued by oeNFRKB."
32351584